Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedLocations section updated with numerous new study sites across the US, Australia, Canada, and multiple other regions. Several previously listed sites were removed or reorganized.SummaryDifference2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.0%

- Check40 days agoChange DetectedThe additions update PubMed source wording and add Revision: v3.3.1; the deletions adjust the PubMed sourcing language and add Revision: v3.2.0.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a study location: Tainan, Taiwan, 70457. The listing was updated to standardize the location as 'Tainan, Taiwan, 70457' and a government funding status notice was removed.SummaryDifference0.2%

- Check62 days agoChange DetectedNo significant changes to the core content; the study details, eligibility criteria, and outcomes appear unchanged, with only minor visual/layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange DetectedCore content updated with an operating-status notice and a version upgrade from v3.0.2 to v3.2.0.SummaryDifference3%

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.